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Abstract. 
 
Whereas the physiological signiﬁcance of mi-
crosomal fatty acid elongation is generally appreciated, 
its molecular nature is poorly understood. Here, we de-
scribe tissue-speciﬁc regulation of a novel mouse gene 
family encoding components implicated in the synthesis 
of very long chain fatty acids. The 
 
Ssc1
 
 gene appears to 
be ubiquitously expressed, whereas 
 
Ssc2
 
 and 
 
Cig30
 
 
show a restricted expression pattern. Their translation 
products are all integral membrane proteins with ﬁve 
putative transmembrane domains. By complementing 
the homologous yeast mutants, we found that 
 
Ssc1
 
 
could rescue normal sphingolipid synthesis in the 
 
sur4
 
/
 
elo3
 
 mutant lacking the ability to synthesize cerotic acid 
 
(C
 
26:0
 
). Similarly, 
 
Cig30
 
 reverted the phenotype of the
 
 
fen1
 
/
 
elo2
 
 mutant that has reduced levels of fatty acids 
in the C
 
20
 
–C
 
24
 
 range. Further, we show that 
 
Ssc1
 
 
mRNA levels were markedly decreased in the brains of 
myelin-deﬁcient mouse mutants known to have very 
low fatty acid chain elongation activity. Conversely, the 
dramatic induction of 
 
Cig30
 
 expression during brown 
fat recruitment coincided with elevated elongation ac-
tivity. Our results strongly implicate this new mamma-
lian gene family in tissue-speciﬁc synthesis of very long 
chain fatty acids and sphingolipids.
Key words: membrane • lipids • elongation • myelin • 
gene expression
 
Introduction
 
Fatty acid species with a maximum chain length of 16–18
carbon atoms account for 
 
.
 
90% of total fatty acids in
most mammalian tissues. However, many biological pro-
cesses depend on fatty acids consisting of 20 and more car-
bon atoms, which are generally referred to as very long
chain fatty acids (VLCFA)
 
1
 
. Although virtually ubiqui-
tous, VLCFA are found at especially high levels in the
brain, skin, testis, and some glands, such as the meibomian
gland (for review see Poulos, 1995).
Only a very small fraction of VLCFA occurs unesteri-
fied; the main fraction of intracellular VLCFA is esterified
in various lipids. Under normal circumstances, a substan-
tial amount of VLCFA is amide-linked to a long-chain
sphingoid base sphinganine, forming a ceramide, which
constitutes the lipid backbone of sphingomyelin and other
sphingolipids. Apparently, the distribution bias for VLCFA
between sphingolipids and e.g., glycerolipids is controlled
by substrate specificity of the corresponding fatty acyl-
transferases, such as ceramide synthase.
Sphingolipids are essential for cell proliferation. Im-
paired sphingolipid synthesis leads to cessation of cell
growth both in yeast (Wells and Lester, 1983) and mam-
malian cells (Hanada et al., 1992). Unique structural prop-
erties of sphingolipids strongly contribute to the epidermal
water barrier (Wertz, 1992), as well as enhance electric in-
sulation of myelin (Bourre et al., 1977). The bulk of sphin-
golipids are located in the plasma membrane, permitting
the complex sugar groups of glycosphingolipids to act in
cell recognition and adhesion (Hakomori and Igarashi,
1995). A large body of evidence has been accumulated
that implicates sphingolipids and their degradation prod-
ucts in signal transduction (Hannun, 1996; Spiegel and
Merrill, 1996; Testi, 1996) and formation of functional
lipid microdomains in the plasma membrane (Simons and
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Ikonen, 1997). Interestingly, suppressor mutations in
sphingolipid-deficient yeast mutants have demonstrated
that glycerophospholipids containing VLCFA can mimic
sphingolipid structures, allowing yeast growth in the ab-
sence of sphingolipid (Lester et al., 1993). Hence, VLCFA
appears to be an essential component of sphingolipid func-
tion.
It is well established that the major site of VLCFA syn-
thesis beyond C
 
18
 
 occurs on the membranes of the ER
(Cinti et al., 1992). The elongation process is similar to the
series of reactions carried out by fatty acid synthase and
involves four steps: condensation, reduction, dehydration,
and a second reduction. It is unclear whether all elonga-
tion reactions are accomplished by a single polypeptide, or
rather by a complex of several subunits. However, several
discrete enzymatic activities, e.g., 
 
b
 
-hydroxyacyl CoA de-
hydrase, have been purified to high homogeneity (Bernert
and Sprecher, 1979), suggesting that the latter possibility is
more likely. Another long-standing question has been
whether or not multiple microsomal elongation systems
exist in the cell with different saturation and/or chain
length specificities. This notion emerged from studies per-
formed on myelin-deficient mouse mutants, namely jimpy
and quaking. In the brains of these mice, arachidoyl CoA
(C
 
20
 
) and behenoyl CoA (C
 
22
 
) elongation activities are de-
creased more dramatically than palmitoyl CoA (C
 
16
 
) elon-
gation (Suneja et al., 1991), supporting the concept of mul-
tiple elongation pathways.
To date, very little is known about the genetic nature of
mammalian fatty acid chain elongation enzymes. Several
putative condensing enzymes involved in VLCFA biosyn-
thesis have been cloned and characterized in plants (Millar
and Kunst, 1997; Millar et al., 1999). In yeast, which are
more akin to mammals in terms of the biochemical roles of
VLCFA, the 
 
ELO
 
 gene family appears to be indispens-
able for fatty acid chain elongation. The first homologue
of this group, 
 
ELO1
 
, is required for microsomal fatty acid
chain elongation between C
 
14
 
 and C
 
16
 
 (Toke and Martin,
1996), an activity which is normally masked by cytoplasmic
fatty acid synthase. The other two 
 
ELO
 
 genes, 
 
ELO2
 
 and
 
ELO3
 
, are necessary for synthesis of VLCFA of up to 24
and 26 carbon atoms, respectively (Oh et al., 1997). For
the reasons mentioned above, low VLCFA levels result in
a dramatic decrease of all three principal sphingolipid
species normally found in 
 
Saccharomyces cerevisiae
 
, i.e.,
inositolphosphorylceramide [IPC], mannose inositolphos-
phorylceramide [MIPC] and mannose diinositolphospho-
rylceramide [M(IP)
 
2
 
C] (Oh et al., 1997). Consequently,
low sphingolipid levels might be the primary cause of the
pleiotropic phenotypes associated with mutations in these
loci. In fact, disruption of either of 
 
ELO2
 
 or 
 
ELO3
 
, that
have been cloned by different groups and synonymically
termed 
 
FEN1/GNS1/SRE2/VBM2 
 
and 
 
SUR4/APA1/SRE1/
VBM1
 
, leads to a broad range of defects, encompassing al-
tered expression of the plasma membrane ATPase gene
and lowered glucose uptake capacity (García-Arranz et
al., 1994), marked reduction in 1,3-
 
b
 
-glucan synthase ac-
tivity (El-Sherbeini and Clemas, 1995), modified phospho-
lipid composition (Desfarges et al., 1993), irregular bud-
ding pattern (Durrens et al., 1995), and resistance to
inhibitors of sterol synthesis (Ladeveze et al., 1993; Silve et
al., 1996). Moreover, mutation in either of these genes also
 
suppresses the phenotype of the 
 
rvs
 
 mutant, which is char-
acterized by reduced viability upon nitrogen, carbon, or
sulfur starvation (Desfarges et al., 1993), and bypasses a
defect in the receptor-mediated secretory pathway, re-
storing normal exocytosis (David et al., 1998). Simulta-
neous disruption of 
 
ELO2/FEN1/GNS1/SRE2/VBM2
 
 and
 
ELO3/SUR4/APA1/SRE1/VBM1
 
 (which, in accordance
with the 
 
S. cerevisiae
 
 Gene Name Registry, will henceforth
be referred to as 
 
FEN1
 
 and 
 
SUR4
 
) is lethal (Revardel et
al., 1995; Silve et al., 1996). If the central tenet about pri-
mary function of these genes holds, the data accumulated
in these studies could provide new and profound insight
into the complexity of the role(s) of VLCFA and sphin-
golipids in the cell.
Previously, we have reported our finding of 
 
Cig30
 
, a
highly inducible mouse gene, the expression of which is as-
sociated with the activity of brown adipose tissue (Tvrdik
et al., 1997). The CIG30 protein is very similar to 
 
FEN1
 
and 
 
SUR4
 
 gene products, but also to a number of genes
identitified in the genome of 
 
Caenorhabditis elegans
 
. As-
suming the presence of multiple genes of this family in the
mouse genome as well, we searched for
 
 Cig30
 
 homologues
and identified two novel genes, which were designated
 
Ssc1
 
 and 
 
Ssc2
 
 (for sequence similarity to 
 
Cig30
 
). We
present evidence that the members of this mouse gene
family participate in the process of VLCFA synthesis.
 
Materials and Methods
 
Animals and Treatments
 
For comparison of 
 
Ssc1
 
, 
 
Ssc2
 
, and 
 
Cig30
 
 expression profiles and for fatty
acid chain elongation studies, NMRI male mice (6–8 wk old) were ob-
tained from a local supplier (Eklunds) and kept at thermoneutral temper-
ature (28
 
8
 
C) for 1 wk. After this period, some animals were exposed to
4
 
8
 
C when indicated. The mice were killed by cervical dislocation and the
tissues were dissected and directly subjected to RNA extraction or ho-
mogenization and differential centrifugation.
To analyze cerebral 
 
Ssc1
 
 mRNA levels in dysmyelinating mutants,
heterozygous breeder pairs of quaking (B6C3Fe-
 
a/a-qk
 
) and jimpy
(B6CBACa-
 
A
 
w-J
 
/A-Ta jp
 
) were obtained from the Jackson Laboratory
and bred in our animal facility. The mutant pups and their healthy litter-
mate controls were killed at the age of 18 d and their brains were quickly
dissected and frozen in liquid nitrogen before RNA extraction.
 
Mouse cDNA Cloning and Sequencing
 
Based on sequence information obtained from the EST sequencing
project, primers were designed to PCR amplify the protein coding regions
of 
 
Ssc1
 
, 
 
Ssc2
 
, and 
 
Cig30
 
 from mouse liver Marathon-Ready cDNA library
(Clontech). The primers used were: primer 1, 5
 
9
 
-GGACGTCGACT-
GAGTCCTTAGCCAGGATGGAGGCTGTTGT-3
 
9
 
 and primer 2, 5
 
9
 
-
GAGCAGATCTGTCCTGAGGCACTTAGGTGGGCAATGTCTA-3
 
9
 
for 
 
Ssc1
 
 ORF amplification; primer 3, 5
 
9
 
-GGACGTCGACCGCGGC-
CGCGCGGCCATGGAGCAGCTGAA-3
 
9
 
 and primer 4, 5
 
9
 
-GAGCA-
GATCTCCACCTCAGTTTGTGTTCCCCGGCACTTCA-3
 
9
 
 for 
 
Ssc2
 
ORF amplification; and primer 5, 5
 
9
 
-GGACGTCGACCGTCTGCAA-
AATCGAAATGGACACATCCAT-3
 
9
 
 and primer 6, 5
 
9
 
-GAGCAGA-
TCTACGGAGGAACGGCTGAGGCTCCATCTTTCT-3
 
9
 
 for 
 
Cig30
 
ORF amplification. To facilitate cloning, all forward primers contain ex-
ogenous SalI sites and all reverse primers contain exogenous BglII sites
(both shown in bold face). The touch-down PCR reactions were per-
formed with the 
 
Pfu
 
 polymerase (Stratagene) for 32 cycles totally (after
denaturation at 94
 
8
 
C for 1 min, 5 cycles 94
 
8
 
C for 30 s, 72
 
8
 
C for 3 min, 5 cy-
cles 94
 
8
 
C for 30 s, 70
 
8
 
C for 3 min, and 22 cycles 94
 
8
 
C for 30 s, 68
 
8
 
C for 3
min). For each gene, at least two independent PCR products were se-
quenced to check that no amplification errors occurred. To obtain the full-
length mRNA sequences of 
 
Ssc1
 
 and 
 
Ssc2
 
, RACE experiments were per-
formed using primer 7, 5
 
9
 
-GGCTATTGGAAAAGTCTATGGGGT- 
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CACA-3
 
9 
 
for 
 
Ssc1
 
 5
 
9
 
 RACE; primer 8, 5
 
9
 
-GGCACCATCTTCTTCAT-
ACTGTTCTCCA-3
 
9 
 
for 
 
Ssc1
 
 3
 
9
 
 RACE; primer 9, 5
 
9
 
-CCAGCATA-
TACGCAGAAAGAAGTGTG-3
 
9 
 
for 
 
Ssc2
 
 5
 
9
 
 RACE; and primer 10, 5
 
9
 
-
GACATACCGGAAAAAGCCAGTGAAGAAA-3
 
9
 
 for 
 
Ssc2
 
 3
 
9
 
 RACE.
The template and PCR conditions were the same as above. 5
 
9
 
 RACE ex-
periments were run for each 
 
Ssc
 
 transcript twice with identical results. The
PCR products were subcloned into pCR-XL-TOPO vector (Invitrogen)
and sequenced using ABI Prisms Dye Terminator Cycle Sequencing
Ready Reaction kit (Perkin-Elmer) with an ABI 373A automatic DNA
sequencer (Applied Biosystems). Sequence data analyses were performed
with the University of Wisconsin Genetics Computer Group package
(Devereux et al., 1984).
 
RNA Isolation and Northern Blotting
 
Total RNA was isolated from fresh or frozen specimens of mouse tissues
(
 
z
 
50 mg) using the Ultraspec RNA isolation protocol (Biotecx Laborato-
ries). RNA electrophoresis, blotting, and hybridization was performed as
previously described (Tvrdik et al., 1997). The cDNA probes for 
 
Ssc1
 
,
 
Ssc2
 
, and 
 
Cig30
 
 were SalI–BglII fragments isolated from their correspond-
ing pEMR yeast expression vectors. The actin probe was as in Tvrdik et al.
(1997). The probes were labeled using random-primed DNA labeling kit
(Boehringer Mannheim) with [
 
32
 
P]dCTP.
 
Yeast Strains and Culture Conditions
 
Yeast strains used in this study and their genotypes are presented in Table
I. They are all FL100 (ATCC 28383) derivatives. For metabolic labeling
and growth studies, all strains were grown on YNBG medium (Difco),
supplemented with tryptophane (EMA41 transformants), tryptophane
and leucine (EMY58 transformants), and tryptophane and uracil
(EMA3). For EMA103 strain, YNBG medium was supplemented with
1% Tergitol, myristic acid (C
 
14
 
, 0.2 mM), palmitic acid (C
 
16
 
, 0.4 mM), and
stearic acid (C
 
18
 
, 0.2 mM). EMA103 transformants were grown on me-
dium supplemented with Tergitol and C
 
14
 
 only. Alternatively, EMY58
transformants were grown on YPGE medium, containing 2% bactopep-
tone (Difco), 1% yeast extract (Difco), 3% glycerol, and 1% ethanol.
 
Yeast Plasmids and DNA Manipulation
 
pEMR1023, a multicopy plasmid containing the selection marker 
 
URA3
 
,
was described previously (Silve et al., 1996). The coding sequences of
 
Ssc1
 
, 
 
Ssc2
 
, and 
 
Cig30
 
 were obtained by PCR amplification as described
above, digested with SalI and BglII, and ligated in the SalI and BglII sites
of the pEMR1023 vector. The pNK451 plasmid was used to disrupt the
 
FAS2 gene according to Alani et al. (1987). Yeast transformation was car-
ried out as described (Gietz et al., 1992).
The SUR4 gene deletion was made as follows: the 1.1-kb PvuII–HpaI
fragment in the coding region of SUR4 was replaced by a 1.4-kb DraI–
MluI fragment, which contained the neo gene derived from transposon
Tn903. The resulting plasmid was digested with BamHI, and the 3.2-kb
fragment encompassing the disruption was used to transform EMY30
cells. Successful SUR4 gene replacement in geneticin-resistant cells was
checked by PCR analysis. Disruptant cells (EMY58) were resistant to 200
mg/ml geneticin and 25 mM SR 31747.
To disrupt the FAS2 gene in the elo1 mutant (EMA45), a knockout
vector was constructed in which two FAS2 genomic regions (correspond-
ing to the promoter and terminator, respectively, nucleotides 830–1,350
and 2,130–2,160, GenBank/EMBL/DDBJ accession no. J03936) were
PCR-cloned and inserted in the EcoRI/BglII and BamHI/SalI sites of the
pNK451 vector to flank the HisG-URA3-HisG sequence. Next, the MluI–
EcoRI fragment encompassing the FAS2-HisG-URA3-HisG-FAS2 cas-
sette was gel-purified and transfected into EMA45. Three colonies were
obtained that were able to grow on synthetic medium supplemented with
Tergitol (1% wt/vol), C14 (0.2 mM), C16 (0.4 mM), and C18 (0.2 mM), but
not on medium supplemented with Tergitol and C14 only. The URA3
marker was then eliminated via HisG–HisG recombination by incubation
in the presence of 59-fluoroorotic acid (1 mg/ml) and uracil, yielding
EMA103. Deletion of the FAS2 gene in EMA103 was finally verified by
PCR and Southern blot analyses.
Sphingolipid Analysis
Overnight cultures of yeast transformants were diluted to z2 3 106 cells/
ml (OD600 5 0.066) and grown in 2 ml of appropriately supplemented
YNBG at 308C in the presence of the radioactive precursor. [3H]serine
(Nycomed Amersham; 20 mCi/ml) was added immediately after dilution
and the cells were labeled for 6 h. [3H]sphinganine and [3H]inositol
(American Radiolabeled Chemicals Inc.; each at 1 mCi/ml in the total
chemical concentration of 10 mM) were added 4.5 h after dilution and the
cells were labeled for 1.5 h. Incubations were terminated by chilling on ice
and 0.5 ml of unlabeled stationary phase cells was added. The cultures
were sedimented at 2,800 g for 10 min at 48C, treated with 5% TCA at 48C
for 20 min, and were then washed once with 5 ml of ice-cold H2O. Lipids
were prepared as described (Hanson and Lester, 1980). In brief, each pel-
let was extracted twice with 1 ml of ethanol/water/diethyl ether/pyridine/
4.2 N NH4OH (15:15:5:1:0.018) at 608C for 15 min. To destroy glycero-
phospholipids, the pooled extracts were optionally treated with 1 ml of
monomethylamine reagent (33% monomethylamine in ethanol, diluted
by 30% [vol/vol] with water) at 528C for 30 min (Clarke and Dawson,
1981). The extracts were then dried in SpeedVac and dissolved in 120 ml
of chloroform/methanol/water (16:16:5). 30 ml of each sample were ap-
plied to Whatman LK5D silica gel TLC plates and resolved in chloroform/
methanol/4.2 NH4OH (9:7:2). When the runs were completed, the plates
were dried at 1008C for 5 min and sprayed several times with EN3HANCE
(New England Nuclear Life Science Products). The signal was visualized
by exposing the TLC plates to DuPont Cronex X-ray films at 2808C for
several weeks.
Preparation of Microsomes and Fatty Acid
Elongation Assay
Interscapular brown fat was dissected and homogenized in 4 ml of ice-cold
0.25 M sucrose. After a 30-min stepwise centrifugation (10 min at each 700 g,
8,000 g, and 17,000 g) at 4 to 108C, the supernatant was carefully trans-
ferred to fresh tubes and microsomes were sedimented at 105,000 g for 45
min. The pellet was resuspended in 20 mM Tris-HCl, pH 7.4, containing
0.4 M KCl, and centrifuged at 105,000 g for 45 min. The final microsomal
pellet was resuspended in 200 ml of 0.1 M Tris-HCl, pH 7.4, and the pro-
tein was measured with the BCA protein assay (Pierce Chemical Co.).
Total fatty acid elongation activity was measured essentially according
to Suneja et al. (1991). The assay mixtures (1 ml total, including protein
addition) contained 0.1 M Tris-HCl, pH 7.4; either 50 mM palmitoyl CoA,
15 mM arachidoyl CoA, or 15 mM lignoceroyl CoA; substrate/BSA ratio
of 2:1; 1 mM NADPH; and 50 mM malonyl CoA (containing 0.20 mCi of
2[14C]malonyl CoA). After 1 min of preincubation at 378C, the reaction
was initiated by the addition of 1 mg of microsomal protein and carried
out for 20 min at 378C. The incubation was terminated by addition of 1 ml
of 15% KOH in methanol and saponified at 658C for 45 min. Then the
samples were cooled and acidified with 1 ml of cold 5 M HCl. Free fatty
acids were extracted from the mixture three times with 3 ml of N-hexane
and dried under vacuum. The extract was dissolved in 1 ml of chloroform
and measured after addition of 10 ml of scintillation mixture in a Beckman
liquid scintillation system 3801.
Results
Cloning of Ssc1 and Ssc2 cDNAs
We compared the Cig30 cDNA sequence to the EST data-
base and found several highly similar nucleotide se-
quences. All mouse EST cDNA fragments seemingly con-
formed to two novel mRNA species. One clone of each
cluster (GenBank/EMBL/DDBJ accession nos. W18104
and W48984) was acquired through the I.M.A.G.E. Con-
Table I. Yeast Strains Used in this Study
Strain Genotype Source or reference
EMA3 Mata ura3 trp1 François Lacroute*
EMA41 Mata ura3 trp1 leu2 fen1::LEU2 Silve et al., 1996
EMA45 Mata ura3 trp1 elo1::TRP1 Pascal Leplatois*
EMA103 Mata ura3 trp1 elo1::TRP1 DFAS2 This study
EMY22 Mata ura3 sur4-232 Silve et al., 1996
EMY30 Mata ura3 trp1 leu2 Silve et al., 1996
EMY58 Mata ura3 trp1 leu2 sur4::GenR This study
*Sanofi Recherche, Labège Innopole, France.The Journal of Cell Biology, Volume 149, 2000 710
sortium. After Northern hybridization of the clones to to-
tal RNA from several mouse tissues, we determined that
both genes were expressed in the liver (data not shown).
The full-length cDNAs were therefore obtained by PCR
amplification from the liver RACE Ready cDNA library
(Clontech). The nucleotide sequences of Ssc1 and Ssc2
cDNA are shown in Fig. 1. Although the length of the
transcripts is markedly different (1.5 kb vs. 3.7 kb), the en-
coded polypeptides are very similar both in size and se-
quence. Amino acid sequence alignment of SSC1, SSC2,
and CIG30 with homologous yeast polypeptides indicates
that sequence identity in each mouse–mouse or mouse–
yeast protein pair is z30%, and they all contain 100% con-
served motifs characteristic of this protein family, such as
KXXEXXDT, FXHXXHH, HXXMYXYY, or TXXQXXQ
(Fig. 2). The HXXHH consensus sequence is commonly
found in fatty acid desaturases (Shanklin et al., 1994).
The SSC proteins are also similar to CIG30 in being
Figure 1. Nucleotide sequences of Ssc1 (A) and Ssc2 (B) cDNAs.
Deduced amino acid sequences of the corresponding SSC
polypeptides are shown below each open reading frame and pu-
tative membrane-spanning domains in both proteins are under-
lined and numbered with Roman numerals. Di-lysine motifs
matching the ER retrieval signal are marked by bold letters.
Polyadenylation signal consensus sequences are underlined with
dashed lines. Sequence data have been deposited with the Gen-
Bank/EMBL/DDBJ data library under accession nos. AF170907
and AF170908.Tvrdik et al. Mouse Genes Involved in Microsomal Fatty Acid Elongation  711
highly hydrophobic. Hydropathy analyses by the GES al-
gorithm (Engelman et al., 1986) suggest that they contain
two NH2-terminal transmembrane regions, followed by an
amphiphilic region, and three to four COOH-terminal
membrane-spanning regions (Fig. 3). Due to the long hy-
drophobic stretch in place of the third putative transmem-
brane region, it is less clear than in other homologues
whether the total number of membrane-spanning regions
is five or six (see also Oh et al., 1997; Tvrdik et al., 1997).
COOH-terminal sequences of both proteins contain an
ER retention signal. The SSC1 polypeptide contains two
lysine residues in positions 23 and 25 (KXKXX), and the
COOH terminus of SSC2 matches the KKXX consensus
sequence (23 and 24; Fig. 1, A and B). Both signals have
been shown to confer maximum ER retention/retrieval ef-
ficiency (Jackson et al., 1990). The ER retention signal in
the CIG30 protein is rather weak, but it does have a lysine
residue in the most critical 23 position (Fig. 2). We have
not detected any other intracellular localization signals.
Previously, we have demonstrated that CIG30 is a glyco-
protein (Tvrdik et al., 1997). However, in the SSC1 pro-
tein, both of the two potential N-glycosylation motifs
(amino acid positions 66–69 and 171–174; Fig. 1 A) are
buried in the putative membrane-spanning regions, and
we found no N-glycosylation consensus sequence in SSC2,
suggesting that the SSC proteins are not glycosylated. The
absence of functional glycosylation sites in these proteins
is also supported by our experiments in which we have
seen no mobility shift of in vitro translated SSC polypep-
tides in the presence of canine microsomal membranes
(not shown).
Expression of Ssc1, Ssc2, and Cig30 in Mouse Tissues
Northern blot analysis revealed that Ssc1 was expressed in
a broad variety of mouse tissues, whereas Ssc2 expression,
similar to Cig30, was rather tissue-specific (Fig. 4). The
highest steady-state levels of Ssc1 mRNA were found in
stomach, lung, kidney, skin, and intestine, whereas white
fat, liver, spleen, brain, brown fat, heart, and muscle
showed moderate Ssc1 expression. Only a very weak Ssc1
mRNA signal was found in the testis. In contrast, the Ssc2
mRNA levels in the testis were the highest of all tissues
tested, followed by liver. Trace amounts of Ssc2 transcript
Figure 2. Amino acid sequence alignment of mouse and yeast
Elo1p homologues. Amino acid positions conserved in at least
50% of the homologues are highlighted. The HXXHH motif,
characteristic of desaturase/hydroxylase enzymes containing a di-
iron-oxo cluster (Fe-O-Fe), is underlined. The alignment was
generated by the PileUp program.
Figure 3. Hydropathy plots
of SSC1, SSC2, CIG30,
Sur4p, Fen1p, and Elo1p
proteins. The plots were cre-
ated by the PepPlot program
using the Goldman, Engel-
man, and Steitz (GES) algo-
rithm. The curves are aver-
ages of residue-specific
hydrophobicity scales (the
GES scales) over a window
of 22 residues, positive val-
ues indicating hydrophobic
regions. The putative trans-
membrane regions are num-
bered with Roman numerals.
Abscissas in all graphs are
drawn to the same scale.The Journal of Cell Biology, Volume 149, 2000 712
were also found in white fat, brain, and kidney. In agree-
ment with our previous results, Cig30 expression was de-
tected in the liver and skin of thermoneutral mice, and it
was strongly elevated in the brown fat of cold-exposed
mice. It is noteworthy that neither Ssc1 nor Ssc2 expres-
sion was notably changed in that condition. The size of
Ssc1 and Ssc2 mRNAs estimated from Northern blots
was in good agreement with the size of their respective
cDNAs.
Complementation of Yeast Mutants with Homologous 
Mouse Genes
Significant sequence similarities between Cig30, Ssc1, and
Ssc2 on the one hand, and ELO1, FEN1, and SUR4 on the
other, suggest a functional equivalency between the mouse
and yeast gene families. To address this issue, we decided
to investigate whether any of the mouse genes could com-
plement for the yeast genes in Dsur4 or Dfen1 yeast mu-
tants. It has been demonstrated that yeast vegetative
growth could be inhibited by the sterol synthesis inhibitor
SR 31747 in a dose-dependent manner (Silve et al., 1996).
As shown in Fig. 5 A, growth of the parental yeast strain
EMA3 was severely inhibited already by 2 mM SR 31747.
After disruption of either SUR4 or FEN1, however, SR
31747 tolerance was greatly enhanced and the resulting
mutants were able to grow in the presence of .35 mM SR
31747. In the first series of experiments (Fig. 5 B), we
transformed the Dsur4 mutant (EMY58) with yeast ex-
pression plasmids containing the genes of interest, and
scored selected colonies for their ability to grow in increas-
ing concentrations of SR 31747. Control transformation
with SUR4 restored SR 31747 sensitivity to the wild-type
levels, whereas FEN1 overexpression had no effect. In this
expression system, Ssc1 clearly conferred SR 31747 sensi-
tivity, although less well than SUR4, and inhibited growth
of the Dsur4 mutant at SR 31747 concentrations of 20–25
mM. Transformation with Cig30 did not affect SR 31747
tolerance in this mutant. The second series of experiments
(Fig. 5 C) performed in the Dfen1 mutant (EMA41) re-
vealed that, predictably, FEN1 restored wild-type SR
31747 sensitivity, but also that SUR4 overexpression con-
ferred nearly as low level of SR 31747 sensitivity as FEN1.
Of the homologous mouse genes, Cig30 consistently com-
plemented the Dfen1 mutant best, conferring growth arrest
at 15–20 mM SR 31747, but Ssc1 could also mediate SR
31747 sensitivity at higher concentrations (25–30 mM).
Ssc2 complementation data were inconclusive in both
yeast mutants (not shown).
Figure 4. Ssc1, Ssc2, and Cig30 mRNA levels in mouse tissues.
Northern blot analyses were performed with 10 mg of total RNA
isolated from the tissues indicated. BAT, 48C, refers to RNA iso-
lated from the brown adipose tissue of a mouse exposed to 48C
for 3 d. All other RNA samples were isolated from animals kept
at thermoneutral temperature (288C). WAT, White adipose tis-
sue; SK. MUSCLE, skeletal muscle. The membranes were
probed with 32P-labeled cDNA fragments corresponding to open
reading frames of Ssc1, Ssc2, and Cig30, respectively, and subse-
quently exposed to DuPont Cronex X-ray films for up to 1 wk.
The positions of the ribosomal 28S and 18S RNAs are indicated
on the left.
Figure 5. Rescue of SR 31747 sensitivity in the Dsur4 and Dfen1
yeast mutants by murine genes. A, Wild-type cells (EMA3). B,
Dsur4 mutants transformed with expression plasmids containing
the indicated genes. C, Dfen1 mutants transformed with the same
range of expression vectors. Dsur4 and Dfen1 alone were trans-
formed with the empty expression vector. The cells were incu-
bated for 48 h on solid medium with increasing concentrations of
SR 31747 (which are given in micromoles per liter above each se-
ries of transformants or wild-type cells). The media used were
minimal synthetic medium supplemented with required amino
acids (YNBG), or complex medium containing bactopeptone,
yeast extract, glycerol, and ethanol (YPGE), as indicated below
each section. Figure represents typical result of three indepen-
dent experiments.Tvrdik et al. Mouse Genes Involved in Microsomal Fatty Acid Elongation  713
In addition to being resistant to SR 31747, the Dsur4 mu-
tant had also been shown to be unable to grow on glycerol/
ethanol (Silve et al., 1996). In good agreement with the
above results, SUR4 or Ssc1 rescued the Dsur4 mutant’s
ability to grow on glycerol/ethanol, whereas the other
genes did not (Fig. 5 B, YPGE). Thus, our data support
the view that Ssc1 is functionally equivalent to SUR4,
whereas Cig30 appears to be similar to FEN1.
Since Ssc2 failed to conclusively complement selected
phenotypic defects in the Dsur4 and Dfen1 mutants, there
remained a possibility that Ssc2 could be functionally
equivalent to Elo1. In contrast to sur4 and fen1, the elo1
mutant does not have any recognizable phenotype (Re-
vardel et al., 1995). However, deletion of the fatty acid
synthase gene uncovers its role in 14- to 16-carbon fatty
acid chain elongation (Toke and Martin, 1996). To gen-
erate a suitable expression host, we disrupted the FAS2
gene (encoding the a subunit of the fatty acid synthase)
in the elo1 mutant, and the resulting Dfas2Delo1 strain
(EMA103) was transformed with the same range of
expression vectors as before. All transformants were
screened for their ability to grow on synthetic complete
medium containing C14. None of the transformed genes
fully rescued the Dfas2Delo1 mutant, except for ELO1 it-
self. A very weak growth was observed for the transfor-
mants expressing SUR4, FEN1, and Cig30. Neither Ssc1
nor Ssc2 allowed any growth at all (not shown). Thus, our
data do not favor the possibility that Ssc2 is a functional
counterpart to ELO1.
Ssc1 Rescues Lethality of the sur4Dfen1 Double Mutant
Simultaneous loss of function in SUR4 and FEN1 leads to
synthetic lethality (Revardel et al., 1995). Therefore, we
asked if any of the mouse genes could support growth in
the double mutant. We first transformed a sur4 mutant
(EMY22) to uracil prototrophy using an Ssc1-expressing
vector. Transformed cells were mated with a fen1 disrup-
tant (EMA41). Diploids were induced to sporulate and
single spore-derived colonies were isolated. Out of 67
Ura1 colonies analyzed, one was correctly devoid of the
wild-type versions of SUR4 and FEN1, as confirmed by
PCR analysis and DNA sequencing (not shown). This
strain resisted the toxic effect of 25 mM SR 31747. To con-
firm that the growth rescue was dependent on Ssc1, we
plated the cells onto medium containing 59-fluoroorotic
acid and uracil, a combination that only allows growth of
Ura2 cells. As anticipated, the double mutant did not yield
any plasmid-cured colonies. In a parallel control experi-
ment, a single sur4 mutant harboring the same Ssc1-express-
ing vector yielded plasmid-cured Ura2 segregants at a
normal level (not shown). These results strongly sug-
gested that Ssc1 was capable of restoring viability in the
sur4Dfen1 double mutant. After Ssc1 loss, synthetic lethal-
ity of the double mutant could not be relieved by any of
the media supplements we have tested, including VLCFA
of 20, 22, and 24 carbon atoms, or ceramide.
We found no conclusive evidence for Cig30 or Ssc2 be-
ing able to restore proliferation in the double mutant. This
could indicate that the mouse genes differ in their capacity
to complement a more extensive biochemical defect in
yeast. Accordingly, SSC1 appears to have the widest speci-
ficity and/or the highest activity.
Ssc1 Is Involved in Biosynthesis of C26 Fatty Acids
and Sphingolipids
Recently, strong evidence has been provided that ELO2/
FEN1 and ELO3/SUR4 are necessary for the synthesis of
fatty acids of up to 24 and 26 carbons, respectively. As a
result,  Dsur4 and Dfen1 mutants have modified sphin-
golipid composition (Oh et al., 1997). These findings
prompted us to investigate whether normal sphingolipid
synthesis could be restored in these mutants by comple-
mentation with the mouse genes. The same range of yeast
transformants used in the previous experiments were met-
abolically labeled with [3H]serine, [3H]sphinganine, or
[3H]inositol, and sphingolipids were isolated and sepa-
rated by thin-layer chromatography. We found no marked
difference in sphingolipid synthesis between wild-type and
the Dfen1 strain (not shown). The Dsur4 mutant showed,
however, a modified sphingolipid pattern as compared
with the parental wild-type strain (Fig. 6). Most notably,
the band corresponding to M(IP)2C was absent in the mu-
tant. This band could not be restored by overexpression of
the FEN1 gene, but complementation with the wild-type
SUR4 gene restored the normal sphingolipid composition.
Importantly, transformation with Ssc1 restored the M(IP)2C,
but the rate of synthesis was below the rate seen in the
wild-type (Fig. 6). Ssc1 also restored normal sphingolipid
synthesis in the sur4Dfen1 double mutant. However, nei-
ther Ssc2 nor Cig30 had any effect. As M(IP)2C contains
almost exclusively cerotoyl (26:0) moieties, we concluded
from this experiment that Ssc1 has the capacity to catalyze
the synthesis of cerotic acid and suggests it to be function-
ally equivalent to SUR4.
Ssc1 Is Markedly Downregulated in the Brains of the 
Myelin-deficient Mouse Mutants Quaking and Jimpy
Brains of the quaking and jimpy mouse mutants are
marked by low VLCFA levels due to a reduced fatty acid
elongation activity (Suneja et al., 1991). Therefore, we
asked whether this decrease would be paralleled by a cor-
respondingly low expression of the candidate gene for
fatty acid elongase in the brain: the Ssc1 gene. As seen in
Fig. 7, the Ssc1 mRNA levels in the brains of 18-d-old
quaking mutants were reduced by 44% as compared with
their normal littermates, while the actin mRNA levels in
the same mutants were only insignificantly reduced by
12%. In the jimpy mutant, the cerebral Ssc1 mRNA levels
were downregulated even more dramatically, being re-
duced by 69%. Actin mRNA levels in the jimpy brain
were only 16% below controls. Thus, reduced fatty acid
chain elongation activities in the brains of quaking and
jimpy mutants indeed appear to correlate with expression
of the Ssc1 gene.
Cig30 mRNA Induction Coincides with Enhanced Fatty 
Acid Chain Elongation Activity during Brown
Fat Recruitment
In this mouse gene family, the most dramatic regulatory
change so far observed is that of Cig30 gene expressionThe Journal of Cell Biology, Volume 149, 2000 714
during brown fat recruitment. Assuming that Cig30 codes
for a component of the fatty acid chain elongation system,
we hypothesized that the induction of Cig30 expression
would be paralleled by an increase in the fatty acid chain
elongation activity. To test this, we isolated microsomal
membranes from brown fat of thermoneutral and cold-
stimulated mice, and determined fatty acid chain elonga-
tion capacity in these samples. Table II shows that elonga-
tion activity was indeed significantly increased in the
brown fat of mice stimulated by low ambient tempera-
ture (48C) for 3 d, relative to thermoneutral controls. The
highest increase (4.73) was observed when palmitoyl CoA
(16:0) was used as substrate. Lower values were obtained
with arachidoyl CoA (20:0) as substrate (4.33). The elon-
gation activity on lignoceroyl CoA (24:0) was induced
least and the increase was insignificant. Hence, our data
demonstrate that elongation of at least two acyl CoA sub-
strates is strongly enhanced in brown fat during recruit-
ment, consistent with the idea that this increase could be
due, in part, to the observed induction of Cig30 expression
(Tvrdik et al., 1997).
Figure 6. Mouse Ssc1 restores glycosphingolipid levels in the Dsur4 yeast mutant. The Dsur4 yeast mutant cells were transformed either
with the empty expression vector (Dsur4 alone), or with plasmids expressing FEN1, SUR4, Cig30, Ssc2, or Ssc1. Along with these trans-
formants, the wild-type cells (EMA3) and the sur4Dfen1 double mutant transformed with Ssc1 were metabolically labeled with
[3H]serine for 6 h, [3H]sphinganine, or [3H]inositol for 1.5 h. Total lipid extracts were prepared and separated by thin-layer chromatog-
raphy. Before chromatography, [3H]serine-labeled lipids shown here were subjected to mild alkaline hydrolysis with methylamine. The
plates were treated with EN3HANCE (New England Nuclear Life Science Products) and exposed to X-ray films for several weeks. The
bands were identified by their relative mobility compared with radioactive standards ([3H]sphinganine) and glycerolipid compounds
were determined in parallel experiments on the basis of their sensitivity to methylamine (not shown). CER, Ceramide; GPC, glycero-
phosphorylcholine; GPE, glycerophosphorylethanolamine; GPS, glycerophosphorylserine; IPC, inositolphosphorylceramide; MIPC,
mannose inositolphosphorylceramide; M(IP)2C, mannose diinositolphosphorylceramide; SPH, sphinganine. Similar results were ob-
tained in a duplicate experiment.
Figure 7. Ssc1 mRNA levels
are severely decreased in the
brains of mouse myelination
mutants quaking and jimpy.
Total RNA was isolated
from the whole brains of 18-
d-old phenotypic mutants
(2/2) or their normal litter-
mates (1/1 or 1/2). 10 mg
of RNA from each animal
was analyzed by Northern
blotting. After hybridization
to  Ssc1 or actin cDNA
probes, the membranes were
quantified with a Phosphor-
Imager (Molecular Dynam-
ics). Each bar represents
mean  6  SEM of four ani-
mals. The means of the con-
trol groups were set to 100.
Statistical differences between mutants and normal littermates
were assessed by unpaired t test. P values: Quaking Ssc1, P 5
0.0120 (**); quaking actin, P 5 0.5837 (NS); jimpy Ssc1, P 5
0.0010 (***); jimpy actin, P 5 0.0199 (*).Tvrdik et al. Mouse Genes Involved in Microsomal Fatty Acid Elongation  715
Discussion
An initial clue about the function of the Cig30 and Ssc
genes was obtained by sequence comparisons, which re-
vealed homology with the yeast ELO gene family. There
are only three members of this family in the yeast genome.
It is not known how many paralogs are present in mamma-
lian genomes, but the fact that C. elegans contains at least
six similar genes (Tvrdik et al., 1997) suggests that the
number of mouse paralogs presented here is not final. We
were unable to identify any clear yeast–mouse ortholo-
gous pair by phylogenic analysis. If anything, Cig30 ap-
pears to be more closely related to the yeast genes,
whereas both Ssc genes seem evolutionarily more distant
(Tvrdik, P., unpublished data). Neither could we recognize
any common protein domains other than the HXXHH
motif previously noticed (Toke and Martin, 1996; Oh et
al., 1997). This histidine-rich motif is found in diiron-oxo
proteins, such as ribonucleotide reductase or various fatty
acid desaturases. Histidine residues act together with as-
partate and glutamate to coordinate the Fe-O-Fe clus-
ter, which is believed to receive electrons from either
cytochrome b5 or a cytochrome b5-like domain in an
NAD(P)H-dependent way (Fox et al., 1994; Shanklin et
al., 1994). This similarity implicates ELO1 homologues in
a redox type of reaction. Therefore, it is reasonable to as-
sume that this group of enzymes could catalyze one or
both of the reduction reactions in fatty acid elongation,
i.e., conversion of b-ketoacyl CoA to b-hydroxyacyl CoA
or reduction of trans-2-enoyl CoA to the saturated acyl
CoA derivative. Further support for this view comes from
plant research. Although VLCFA in plants, in contrast to
the animal kingdom, are almost solely used as constituents
of surface coverings, such as wax, the chemistry of fatty
acid elongation is fundamentally similar. Several putative
condensing enzymes (which catalyze the first rate-limiting
step in fatty acid elongation leading to b-ketoacyl CoA
formation) have been cloned in plants (Millar and Kunst,
1997; Millar et al., 1999; Todd et al., 1999) and shown to
stimulate VLCFA synthesis after expression in various
heterologous systems, including yeast (Millar and Kunst,
1997). None of the plant condensing enzymes, however,
share significant homology with SSC1, SSC2, CIG30,
Sur4p, Fen1p, or Elo1p. Thus, if we exclude the possibility
that two unrelated fatty acid chain elongation systems
have evolved in plants and animals, sequence comparisons
suggest that CIG30 and the SSC proteins are not involved
in b-ketoacyl CoA synthesis, but possibly in b-ketoacyl
CoA or trans-2-enoyl CoA reduction.
A major fraction of noncytoplasmic fatty acid chain
elongation activity resides in the membranes of the ER.
Consistent with their role in VLCFA synthesis, both Sur4p
and Fen1p were localized by immunofluorescence of HA
epitope-tagged proteins to intracellular structures, which
were identified as ER or early Golgi apparatus (David et
al., 1998). Further, as shown in Fig. 1, the COOH-terminal
sequences of the SSC1 and SSC2 polypeptides contain
perfect consensi for ER retrieval signals, suggesting that
the mouse proteins reside in the ER as well. In contrast,
we initially localized the CIG30 protein by GFP tagging
primarily to the plasma membrane (Tvrdik et al., 1997).
However, since the GFP protein was linked to the COOH
terminus of CIG30, this discrepancy could possibly be ex-
plained by inefficient retrieval of the CIG30–GFP fusion
protein from the Golgi due to a misplacement of the ER
localization motif. As a result, most of the fusion protein
could perhaps have been mistargeted to the plasma mem-
brane, presumably in synergy with the weak ER retrieval
signal in CIG30 (lysine residues in the –3 and –7 positions,
compare Fig. 2).
Moreover, we have earlier established that the single
N-glycosylation consensus site in the NH2 terminus of
CIG30 is glycosylated (Tvrdik et al., 1997), indicating that
the NH2-terminal domain sees the inner side of ER. Given
that all Elo1p homologues are integral membrane proteins
sharing a similar topology with five plausible transmem-
brane regions (Oh et al., 1997; Tvrdik et al., 1997; Fig. 3), it
can be predicted that their NH2 termini are located in the
ER lumen, whereas their COOH-terminal segments are
exposed to the cytoplasm.
Complementation in yeast mutants allowed us to un-
cover specific functional relationships between the
yeast and mouse genes, which could not be detected by
sequence comparisons. Thus, our experiments clearly
demonstrate that Ssc1 is functionally orthologous to
SUR4, because in all complementation tests, it restored a
wild-type–like phenotype to the Dsur4 mutant. Specifi-
cally, we showed that Ssc1 expression is able to recover the
synthesis of M(IP)2C (see Fig. 6). Oh et al. (1997) attrib-
uted low glycosphingolipid levels in the elo3/sur4 mutant
to impaired VLCFA metabolism. Indeed, even though the
total levels of long chain fatty acid were z20% increased
in the elo3/sur4 mutant, C26 species were entirely absent.
Under normal circumstances, aOH-C26 is the predominant
fatty acid found in M(IP)2C (Dickson, 1998). This suggests
that SSC1, unlike the other mouse paralogs, is able to uti-
lize C24 CoA as a substrate for elongation. Given the virtu-
Table II. Brown Fat Microsomal Fatty Acyl Chain Elongation Activity in Warm- and Cold-acclimated Mice
Substrate BAT (288C) BAT (48C) Relative increase in cold P value
pmol Mal-CoA/min/mg prot 3
palmitoyl CoA (C16)* 1.80 6 0.64 8.50 6 1.51 4.7 0.004
arachidoyl CoA (C20)* 0.37 6 0.05 1.57 6 0.52 4.3 0.065
lignoceroyl CoA (C24)‡ 0.33 6 0.06 1.12 6 0.56 3.4 0.229
Total fatty acid chain elongation activities in the presence of NADPH were determined in microsomal fractions prepared from brown adipose tissue (BAT) of mice either kept at
thermoneutral temperature (28°C) or exposed to the cold for 3 d (4°C). Specific activity was expressed as picomoles of radioactive malonyl CoA (Mal-CoA) incorporated into
hydrophobic long chain fatty acid fraction by 1 mg of microsomal protein in 1 min. Statistical significance of the increase was determined by unpaired t test.
*Value represents the mean 6 SEM of two experiments performed in triplicate. 
‡Value represents the mean 6 SEM of one experiment performed in triplicate. The Journal of Cell Biology, Volume 149, 2000 716
ally ubiquitous expression of the Ssc1 gene in the mouse
(Fig. 4), it can be inferred that most mammalian tissues
are endowed with an enzymatic capacity to synthesize
VLCFA up to C26 or more. Interestingly, the Ssc1 mRNA
levels were particularly high in the stomach, lung, kidney,
skin, and intestine. Common to all these tissues is that they
separate compartments widely differing in water content.
Therefore, it is conceivable that higher SSC1 levels are
necessary to bring about sufficient VLCFA production in
order to reduce the water permeability of the barrier epi-
thelia (Zeidel, 1996).
Further linking Ssc1 to mammalian VLCFA metabo-
lism, we show in Fig. 7 that quaking and jimpy mouse mu-
tants have dramatically decreased cerebral Ssc1 mRNA
levels. Both mutants are easily recognizable as they de-
velop intense tremor at the age of about two weeks as a re-
sult of severe demyelination of the central nervous system.
Although the molecular mechanisms causing demyelina-
tion in each mutant are very different, in both cases they
eventually lead to massive oligodendrocyte death (Hardy,
1998; Vela et al., 1998). Among the multiple lipid defects
known to take place during brain development in the mu-
tants, fatty acid elongation activity has been investigated
by several groups in great detail. In their study, Suneja et
al. (1991) showed that microsomal fatty acid chain elonga-
tion activity in the brains of quaking mutant mice relative
to controls were 45 and 52% decreased when using arachi-
doyl CoA (C20) and behenoyl CoA (C22) as substrates, re-
spectively. Similar values in jimpy were 77 and 81% below
controls. This correlates strikingly well with 44% decrease
in quaking Ssc1 mRNA levels and 69% decrease in jimpy
Ssc1 mRNA levels that we report in this study, suggesting
that the severity of the elongation defect is proportional to
the reduction in Ssc1 expression. However, Suneja et al.
(1991) also found that in both mutants only the condensa-
tion activity was reduced, whereas reduction and dehydra-
tion steps were unaffected, implicating a defect in the con-
densing enzyme. This would disagree with a role for Ssc1
in a reduction reaction, which we tentatively propose on
the basis of sequence comparisons.
Cig30 appears functionally equivalent to FEN1 as it con-
fers a similar level of sensitivity to the inhibitor of ergos-
terol biosynthesis (as depicted in Fig. 5 C). Interpretation
of this experiment is more complex, because overexpres-
sion of SUR4 could also increase SR 31747 sensitivity in
the fen1 mutant. It has been previously observed that both
enzymes have overlapping activities in such a way that
SUR4 can partially substitute for FEN1, but not vice versa
(Silve et al., 1996). In the light of the tentative biochemical
function of these proteins, this observation could probably
be explained by a broader substrate specificity of the
Sur4p enzyme. Interestingly, Ssc1 was also able to partially
restore SR 31747 sensitivity in the fen1 mutant (Fig. 5 C),
corroborating the hypothesis that Ssc1/SUR4 and Cig30/
FEN1 are orthologous pairs. Further, there is a structural
similarity between Cig30 and FEN1 in having a single
N-glycosylation site in their proximal NH2 termini (El-
Sherbeini and Clemas, 1995; Tvrdik et al., 1997). In terms
of sphingolipid synthesis, however, we could not consis-
tently detect any effect of FEN1 disruption, which would
have allowed an assessment of substitution with Cig30.
This could be considered in line with the theoretical pre-
diction, because the complex yeast glycosphingolipids con-
tain mainly C26, which cannot be made by Fen1p (Oh et
al., 1997). Nevertheless, both Oh et al. (1997) and David et
al. (1998) observed a significant (.60%) reduction in
MIPC and M(IP)2C levels as a result of FEN1 deletion.
This inconsistency could be partly attributable to the ge-
netic variability of different yeast strains that may differ in
the relative amount of fatty acids that FEN1 contributes to
the total VLCFA pool.
In mice, Cig30 expression is tightly associated with activ-
ity of brown adipose tissue (Tvrdik et al., 1997). Within
several days upon appropriate stimulation, such as low
ambient temperature, brown fat Cig30 mRNA becomes
very abundant (Fig. 4). Here, we show that brown fat re-
cruitment is also accompanied by concomitantly elevated
microsomal fatty acid chain elongation activity (Table II).
Although the magnitude is different (an approximate five-
fold increase in elongation activity as opposed to a .200-
fold increase in Cig30 transcripts), our results are not in-
consistent with a role for Cig30 in brown fat microsomal
fatty acid elongation. Our finding also raises questions as
to what is the physiological purpose of enhanced fatty acid
elongation in brown fat recruitment. A possibility is that
the elevated fatty acid elongation activity furnishes fatty
acids for the needs of greater membrane production.
Brown fat recruitment is known to bring about tissue hy-
perplasia, which employs mechanisms such as accelerated
cell proliferation and mitochondriogenesis (Trayhurn and
Nicholls, 1986). Obviously, these processes require aug-
mented phospholipid synthesis. It is also possible that the
elevated Cig30 expression is specifically involved in sphin-
golipid synthesis, as it has been shown that the amount of
the major ganglioside in brown fat, GM3, is significantly
increased during the process of brown fat recruitment
(Kuroshima and Ohno, 1990).
Presently, we are unable to assign any specific activity to
Ssc2. It conferred no significant complementation in the
yeast mutants, including the Dfas2elo1 disruptant. Thus, it
remains an open question whether mammals possess the
elusive ELO1-like enzymatic activity, which in wild-type
cells completely overlaps with fatty acid synthase. How-
ever, the failure of Ssc2 to complement could have been
due to other factors, such as a lack of proper interaction
with other proteins in the yeast elongation complex, or an
insufficient level of expression. It is also possible that
SSC2 could have a different substrate specificity. Ssc2 ex-
pression is particularly high in the testis (Fig. 4), one of the
richest sources of polyenoic long chain fatty acids in the
body, which might suggest that SSC2 specifically interacts
with polyunsaturated fatty acid species.
In summary, extreme hydrophobicity of the enzymes in-
volved in microsomal fatty acid elongation has hindered
isolation and characterization of these complexes. We
have circumvented this obstacle by using the approach of
reverse genetics and have cloned novel mammalian genes
that are strongly implicated in VLCFA synthesis. Our re-
sults reveal similarities between yeast and mammalian
fatty acid elongation and support the view that several
mammalian membrane-bound elongation complexes exist
with different sets of subunits. Some subunits are ex-
pressed in a tissue-specific manner, allowing VLCFA syn-
thesis to be finely tuned in different tissues and differentTvrdik et al. Mouse Genes Involved in Microsomal Fatty Acid Elongation  717
stages of development. By cloning the first components,
our work takes the initial step towards the possibility of re-
constituting membrane-bound fatty acid chain elongation
complexes in vitro.
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